SORIN AORTIC VALVE DLA21

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-03-20 for SORIN AORTIC VALVE DLA21 manufactured by Sorin Group Italia S.r.l..

Event Text Entries

[184665664] Early prosthetic sorin aortic valve failure with prosthetic aortic stenosis and insufficiency. Valve implanted (b)(6) 2015. On (b)(6) 2020, redo sternotomy with aortic valve replacement utilizing edwards inspiris resilia 23 mm bovine pericardial tissue valve. Fda safety report id# (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5093870
MDR Report Key9865194
Date Received2020-03-20
Date of Report2020-03-18
Date of Event2020-02-22
Date Added to Maude2020-03-23
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationRISK MANAGER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSORIN AORTIC VALVE
Generic NameHEART-VALVE, MECHANICAL
Product CodeLWQ
Date Received2020-03-20
Catalog NumberDLA21
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerSORIN GROUP ITALIA S.R.L.


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.